Imiquimod


Generic Medicine Info
Special Precautions
Patient with pre-existing autoimmune conditions, reduced haematologic reserve. Organ transplant patients. Not indicated for urethral, intravaginal, cervical, rectal, or intra-anal human papilloma viral disease. Pregnancy and lactation. Patient Counselling Avoid contact with eyes, lips, nostrils and broken skin. Avoid use of occlusive dressing. Avoid exposure to direct sunlight, UV lights, and tanning beds. Monitoring Parameters Assess for reduction in lesion size. Monitor for local skin reactions and signs and symptoms of hypersensitivity.
Adverse Reactions
Significant: Local inflammatory reactions (e.g. skin weeping, erosion), photosensitivity, flu-like symptoms, vulvar swelling, hypersensitivity. Gastrointestinal disorders: Nausea, diarrhoea. General disorders and administration site conditions: Fatigue. Musculoskeletal and connective tissue disorders: Myalgia, back pain. Nervous system disorders: Headache. Skin and subcutaneous tissue disorders: Burning, itching, excoriation, crusting, flaking, oedema.
ATC Classification
D06BB10 - imiquimod ; Belongs to the class of topical antivirals used in the treatment of dermatological diseases.
Disclaimer: This information is independently developed by CIMS based on imiquimod from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in